Diversified Tracked since Q3 FY26 - Q3 FY26

Zim Laboratories Ltd

Compare with...

ZIMLABORATORIES

Latest quarter Q3 FY26

Revenue ₹109 Cr

Management credibility Building

Promise tracking available after 2+ quarters of coverage.

View all executive profiles for Zim Laboratories Ltd

Latest signal neutral medium

Zim Laboratories reported Q3 FY26 operating income of ₹1,087 crore, with EBITDA of ₹145 crore (13.4% margin) and PAT...

Quarterly Earnings Timeline

Financial verification status, call summary, sentiment, and management-delivery signals by quarter.

1 quarter

Q3 FY26 10 Feb 2026

Revenue ₹109 Cr

Zim Laboratories reported Q3 FY26 operating income of ₹1,087 crore, with EBITDA of ₹145 crore (13.4% margin) and PAT of ₹44 crore, showing sequential improvement.

neutral medium

Scorecard starts after historical backfill Read full analysis →